Mercer Global Advisors
RXST icon

Mercer Global Advisors’s RxSight RXST Stock Holding History

Mercer Global Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
42,417
+25,454
+150% +$154K ﹤0.01% 3222
2026
Q1 		$104K Buy
+16,963
New +$141K ﹤0.01% 3008

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mercer Global Advisors's RXST Position: Q2 2026 in Review

Mercer Global Advisors increased its RxSight (RXST) stake by 150% in Q2 2026, buying an estimated $154K and bringing the position to 42,417 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Mercer Global Advisors first reported a position in RXST in Q1 2026 and has held it in 2 quarters since. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Mercer Global Advisors held 42,417 shares of RxSight worth $204K as of Q2 2026.
  • Mercer Global Advisors bought 25,454 RxSight shares in Q2 2026, an estimated $154K.
  • RxSight made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3222 holding.
  • Mercer Global Advisors first reported a position in RxSight in Q1 2026 and has held it in 2 quarters since.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.